CSL has been given approval by the European Commission for Andembry, the first once-monthly preventive therapy for the ...

Opdualag – which combines the PD-1 inhibitor nivolumab in BMS' blockbuster cancer drug Opdivo with LAG-3 inhibitor relatlimab ...

Pope Francis was being hospitalized Friday for the fourth time since he was elected pope in 2013, after he was diagnosed with bronchitis last week. Francis had part of one lung removed as a young man ...

Total operating expenses for the fourth quarter of 2024 were $287 million, including non-cash stock-based compensation of $40 ...

Pioneering license agreement with BrainTransporter signed with BMS worth up to USD 1.35 billion plus royalties Events during the fourth quarter 2024 The Australian Medicines Agency (TGA) decided not ...